The purposes of this study were to access the effectiveness of high-dose dual therapy (HDDT) for treating Helicobacter pylori resistant to former eradication, examine the side effects of the regimen as well as compliance of patients, identify the distribution of CYP2C19 polymorphism and its influences on the Helicobacter pylori cure rate.